Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and Tumor Lysis Syndrome

capecitabine has been researched along with Tumor Lysis Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engin, H; Eren, OO; Güler, N; Kurt, M1
Cho, SJ; Choi, IJ; Han, HS; Kim, CG; Kim, NK; Kim, SY; Kook, MC; Lee, JR; Lee, JS; Park, SR; Park, YI1

Other Studies

2 other study(ies) available for capecitabine and Tumor Lysis Syndrome

ArticleYear
Tumor lysis syndrome following a single dose of capecitabine.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:5

    Topics: Adult; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Tumor Lysis Syndrome

2004
Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Feb-20, Volume: 26, Issue:6

    Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Cisplatin; Deoxycytidine; Fluorouracil; Hepatomegaly; Humans; Immunohistochemistry; Liver Neoplasms; Male; Risk Factors; Stomach Neoplasms; Tomography, X-Ray Computed; Tumor Lysis Syndrome

2008